Member Info for Mikey279

This process has taken many months but we are now ready to go and have a number of ICBs already warmed up.

Massive massive massive - they're all lined up and now can fund it!!

As noted above the Company believes that access to ERF represents a step change in the Company's commercial prospects. Although customer desire for Bleepa is well established, contracts have been difficult to unlock due to an inability for sites to source funding for the product. This is in large part because most technology funding is capital based rather than revenue based and is more difficult to ringfence, often being redirected for other priority spend such as to offset staff strikes or building repairs.

ERF is expected to enable the Company to align itself to service-based reimbursement, taking a share of service delivery payments. Service-based payments are typically revenue-based and ringfenced, they are also likely to recur because they underpin core areas of service delivery or to be replaced with a different mechanism that recognises the same elements of service delivery providing greater funding security.

the moment a few sign up the rest will too - 10-20x opp from here now

Brilliant work by Tom and team

All IMO

Don't think the market are understanding the scale of this yet, i've followed bleepa for several years now, but 40x 2m, vs a 6m mcap

wouldnt be surprised to see all time highs over the coming weeks

All IMO

Don’t get me wrong I think it’s a bust but not yet

PSE has received a high level of attention within the industry because of its accuracy and ease of use. This has led to ongoing discussions with two of the leading diagnostic services companies in the US for a distribution deal that would widen access to the test and have the potential to add significant volume.

Not to mention the sale or licensing of other items, enough time before q1 to achieve

All IMO

Let’s see who’s right,

De-ramping on fundamentals can only go so far, even if they are in fact worth zero, as traders will appear to prop it up with no care, you see shell companies and companies with de-list confirmations do 1000% in the past - its in that territory IMO

Don't worry I'm not even in, im just observing, - you will see my comments back in the 5p levels and of recent days

The BOD are garbage, but the charts look bottomed out

All IMO

If you learn about volume and charts - you will understand why

I think it'll have one last hurrah probably in the form of a licensing agreement or so then a raise a bit higher by end of year,

funds required for Q1 -

FWIW i still think it goes bust as not enough time to realise value, but one more run before then

looks well bottomed

All IMO

PSE has received a high level of attention within the industry because of its accuracy and ease of use. This has led to ongoing discussions with two of the leading diagnostic services companies in the US for a distribution deal that would widen access to the test and have the potential to add significant volume.

Looks good for a massive breakout on the chart, no reason why this isn’t over £10 really

All IMO

I did, please paste the line where it says 70/30 as it doesn’t exist other than in your FUD comments and well done for admitting you are also stocky

Silly sausage

Don’t really understand this share constant pdmr buys great results but never moves - is there still some sort of overhang from the takeover shenanigans?

Why not post on your stocky account silly sausage?

I’ve done my research and expect 50x from here in a few years

Thanks

All IMO

Absolute joke really

Or just take it for free if EML goes bust ?

Negotiate what exactly...are there enough funds for a new application and enough to last the whole process again or what if there is no way out...?

All IMO

Cash shell puts this at 0.2 or so...?

All IMO

Must be confetti or admin coming soon....

All IMO